RIVERDALE, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)AKTIV AGAINST CANCER INC, founded in 2012, is a small nonprofit in the Medical Research sector that reported $340K in total revenue in fiscal year 2023. Revenue surged 58% from the prior year, signaling strong growth momentum.
AKTIV AGAINST CANCER WORKS TO ENSURE THAT PHYSICAL ACTIVITY WILL BE AN INTEGRAL PART OF CANCER TREATMENT. OUR FOCUS IS THE PROMOTION OF PHYSICAL ACTIVITY AS A MEANS TO PREVENT CANCER.
ACTIVE AGAINST CANCER IS WORKING TO GET PHSYICAL ACTIVITY AS PART OF CANCER TREATMENT. ESTABLISHING PHYSICAL ACTIVITY CENTERS IN CANCER TREATMENT FACILITIES IS ESSENTIAL TO ACHIEVING THIS GOAL. OUR...
ACTIVE AGAINST CANCER IS WORKING TO GET PHSYICAL ACTIVITY AS PART OF CANCER TREATMENT. ESTABLISHING PHYSICAL ACTIVITY CENTERS IN CANCER TREATMENT FACILITIES IS ESSENTIAL TO ACHIEVING THIS GOAL. OUR GOAL IS TO CREATE LOW THRESHOLD FITNESS AND ACTIVITY CENTERS WHERE CANCER PATIENTS CAN RECEIEVE THE EXPERT GUIDANCE OF PROFESSIONALS IN A SAFE. PATIENTS CAN RECEIEVE THE EXPERT GUIDANCE OF PROFESSIONALS IN A SAFE, SOCIAL AND FRIENDLY ENVIRONMENT. AKTIV AGAINST CANCER SUPPORTS VARIOUS RESEARCH PROJECTS TO STUDY THE PREVENTIVE EFFECT OF PHYSICAL ACTIVITY ON CANCER. AKTIV AGAINST CANCER SUPPORTS AN EXCHANGE PROGRAM WITH OSLO UNIVERSITY HOSPITAL, WHICH HELPS TRAIN ETHIOPIAN DOCTORS IN THE FIELD OF ONCOLOGY.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $340,290 | $215,855 | +0.6% |
| Expenses | $350,809 | $326,950 | +0.1% |
| Net Income | $-10,519 | $-111,095 | -0.9% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| HELLE AANESEN | CHAIR | 5.00 |
Director
|
$0 | $0 | $0 |
| JENNIFER THOMAS | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| CHRISTOPHER TORRENTE | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| LARS SCOTFIELD | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| DR MAGGIE ROW | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| AUDREY MCIRNENEY | BOARD MEMBER | 1.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $340,290 | $350,809 | $82,259 | $-10,519 |
| 2022 | $215,855 | $326,950 | $89,146 | $-111,095 |
| 2021 | $391,519 | $312,706 | $200,965 | $78,813 |
| 2020 | $401,553 | $383,329 | $114,261 | $18,224 |
| 2019 | $568,216 | $512,124 | $97,558 | $56,092 |
| 2018 | $343,461 | $289,193 | $69,666 | $54,268 |
Compare AKTIV AGAINST CANCER INC with other nonprofits in New York and across the country.